Bibliographic citations
Boyer, J., (2023). Factores de riesgo asociados a la presentación de icteria neonatal patológica de recien nacidos del hospital de Chulucas, 2021 [Tesis, Universidad Privada Antenor Orrego - UPAO]. https://hdl.handle.net/20.500.12759/10327
Boyer, J., Factores de riesgo asociados a la presentación de icteria neonatal patológica de recien nacidos del hospital de Chulucas, 2021 [Tesis]. PE: Universidad Privada Antenor Orrego - UPAO; 2023. https://hdl.handle.net/20.500.12759/10327
@misc{renati/374717,
title = "Factores de riesgo asociados a la presentación de icteria neonatal patológica de recien nacidos del hospital de Chulucas, 2021",
author = "Boyer Alata, Juan Manuel",
publisher = "Universidad Privada Antenor Orrego - UPAO",
year = "2023"
}
To determine risk factors associated with the presentation of pathological neonatal jaundice in newborns at the Hospital de Chulucanas, 2021”. Methods: An observational, non-experimental analytical design, case-control, retrospective study was carried out. Cases were defined as live newborns diagnosed with jaundice and were matched with healthy newborns. A ratio of 2 controls for each case was established, with a final sample of 69 cases and 138 controls. The documentary review technique was used through a data collection form. Multivariate analysis was performed by calculating Odds ratio and confidence intervals in the statistical program Stata v16. Results: The most predominant maternal age range was 20 to 34 years (60.9% of cases vs. 64.5% of controls). Vaginal delivery was present in 81.2% of cases and 46.4% of controls. The presence of neonatal asphyxia was more common among cases than controls (7.2% vs 1.4%), like the frequency of neonatal sepsis (5.8% vs 1.4%). Gestational age <37 weeks was identified in 39.1% of cases and 7.3% of controls. In multivariate analysis, vaginal delivery (OR=2.87, 95%CI=1.68-4.90, p<0.001) and gestational age <37 weeks (OR=2.56, 95%CI=1.89-3.47, p<0.001) were found as risk factors. Conclusions: Knowledge of the risk factors for neonatal jaundice helps to prioritize the group of neonates requiring more intensive follow-up for early identification and timely management.
This item is licensed under a Creative Commons License